回首頁
回首頁
 


紐約市新冠病毒新變種B.1.526
疫苗效力變弱 傳染率更高

 

兩份最新公布的研究表明,紐約市出現新型新冠變種病毒,且已迅速傳播;這一新變種病毒或能使目前已有的疫苗部分失效,且可能會使傳染率更高。

據紐約時報24日報導,由加州理工學院和哥倫比亞大學分別進行的兩項研究,都發現了該新變種病毒;加州理工學院的研究結果23日晚間在網路發布尚未正式定稿的預印本(preprint),哥大的研究成果則已提交預印本,但尚未公開。

兩份研究都只是初步成稿,尚未經同行評議、正式出版;但兩份研究都表明,在紐約市出現的變種新冠病毒存在且已傳播了數月。

根據新研究,被稱為「B.1.526」的變種病毒11月就已在紐約市出現,而該變種病毒又有兩種不同的基因突變;名為「E484K」的基因突變,或會使目前的疫苗對病毒部分失效,另一個名為「S477N」的基因突變,則會優化新冠病毒綁定人類細胞的過程,進而增加傳染率。
研究表明,此變種病毒目前已在紐約市迅速傳播,科學家們所共享的一份新冠病毒數據庫中,已有27%的病毒序列是該變種病毒。

2021-02-24

 

New coronavirus variant identified in New York

Michael Geheren

NEW YORK (NewsNation Now) — A new coronavirus variant that could be more transmissible and intractable than the traditional strain is on the rise in New York City, researchers said on Wednesday.

Two studies — one from Columbia University and another from the California Institute of Technology — identified the new variant as B.1.526. Outside experts have reviewed neither study.

The new variant, which shares similarities with that of one discovered first in South Africa, was first identified in samples collected in New York in November. By mid-February, it represented about 12% of cases, researchers at Columbia University Vagelos College of Physicians and Surgeons said on Wednesday.

The Columbia researchers said an analysis of publicly available databases did not show a high prevalence of coronavirus variants recently identified in South Africa and Brazil in case samples from New York City and surrounding areas.

“Instead, we found high numbers of this home-grown lineage,” Dr. Anne-Catrin Uhlemann, assistant professor in the division of infectious diseases at Columbia University’s College of Physicians and Surgeons, said in a statement to Reuters.

The Columbia study found that B.1.526 shares some worrying characteristics with B.1.351, the variant first identified in South Africa, and P.1., which was first identified in Brazil. Several studies have suggested that those new variants are more resistant to some existing vaccines than earlier versions of the coronavirus.

The researchers said the main concern is a change in one area of the virus’s spike protein, called E484K, present in all three variants. The E484K mutation is believed to weaken the body’s immune response to the virus.

California Institute of Technology detected the variant using a software tool they developed for quickly examining spike mutations.

“Using this tool, we detected an emerging lineage of viral isolates in the New York region that shares mutations with previously reported variants,” researchers said.

Studies have shown that recently launched coronavirus vaccines are still likely to neutralize the virus and protect against severe illness, even for infections with new variants. Vaccine makers are also working to develop booster shots to combat mutated versions of the virus.

Reporting by Deena Beasley and Reuters.

Reuters contributed to this report.

Categories: Coronavirus

Tags:

 

台灣e新聞